Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria,
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …

In the past 8 years, both the International Working Group (IWG) and the US National Institute
on Aging–Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's …

During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD)
considering the disease as a continuum. Thanks to evolving biomarker research and …

In 2018, the US National Institute on Aging and the Alzheimer's Association proposed a
purely biological definition of Alzheimer's disease that relies on biomarkers. Although the …

Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …

A molecular test for Alzheimer's disease could lead to better treatment and therapies. We
found 18 signaling proteins in blood plasma that can be used to classify blinded samples from …

Alzheimer’s disease (AD) is characterized by the spread of tau pathology throughout the
cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals, …

Tau pathology is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive
aging. Using the tau PET agent 18 F-AV-1451, we examined retention patterns in cognitively …

Resting-state or intrinsic connectivity network functional magnetic resonance imaging provides
a new tool for mapping large-scale neural network function and dysfunction. Recently, we …

See Sarazin et al . (doi: 10.1093/brain/aww041 ) for a scientific commentary on this article.
The advent of the positron emission tomography tracer 18 F-AV1451 provides the unique …